TAO Synergies Inc. (TAOX)
NASDAQ: TAOX · Real-Time Price · USD
8.40
-0.80 (-8.70%)
At close: Aug 15, 2025, 4:00 PM
8.60
+0.20 (2.38%)
After-hours: Aug 15, 2025, 5:51 PM EDT
Company Description
TAO Synergies Inc. owns and operates an AI token. The company executes a cryptocurrency treasury strategy centered on the acquisition and staking of the TAO token, the native utility token of the Bittensor network.
TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025.
The company was incorporated in 2012 and is headquartered in New York, New York.
TAO Synergies Inc.
Country | United States |
Founded | 2012 |
Industry | Software - Infrastructure |
Sector | Technology |
Employees | 4 |
Contact Details
Address: 1185 Avenue of the Americas, 3rd Floor New York, New York 10036 United States | |
Phone | 973 242 0005 |
Website | taosynergies.com |
Stock Details
Ticker Symbol | TAOX |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001571934 |
ISIN Number | US87167T3005 |
Employer ID | 46-1585656 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Joshua N. Silverman | Executive Chairman of the Board |
Dr. Daniel L. Alkon M.D. | President and Director |
Robert Weinstein | Chief Financial Officer, Executive Vice President, Treasurer and Secretary |
Dr. Alan J. Tuchman M.D., MBA(FAAN) | Chief Medical Officer and Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Aug 14, 2025 | S-3 | Registration statement under Securities Act of 1933 |
Aug 14, 2025 | 10-Q | Quarterly Report |
Aug 8, 2025 | 8-K | Current Report |
Aug 6, 2025 | 8-K | Current Report |
Jul 18, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Jul 17, 2025 | EFFECT | Notice of Effectiveness |
Jul 17, 2025 | 8-K | Current Report |
Jul 15, 2025 | UPLOAD | Filing |
Jul 11, 2025 | S-3 | Registration statement under Securities Act of 1933 |